Crossmark Global Holdings’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.6M Sell
33,190
-1,312
-4% -$103K 0.04% 364
2025
Q1
$2.5M Sell
34,502
-232
-0.7% -$16.8K 0.04% 362
2024
Q4
$2.57M Sell
34,734
-101
-0.3% -$7.48K 0.05% 338
2024
Q3
$2.3M Sell
34,835
-6,617
-16% -$437K 0.04% 380
2024
Q2
$3.83M Sell
41,452
-83
-0.2% -$7.67K 0.07% 275
2024
Q1
$3.97M Sell
41,535
-3,245
-7% -$310K 0.08% 269
2023
Q4
$3.42M Sell
44,780
-3,495
-7% -$267K 0.07% 287
2023
Q3
$3.52M Buy
48,275
+511
+1% +$37.3K 0.08% 271
2023
Q2
$4M Sell
47,764
-709
-1% -$59.4K 0.09% 255
2023
Q1
$4.01M Sell
48,473
-1,430
-3% -$118K 0.09% 240
2022
Q4
$3.72M Buy
49,903
+4,205
+9% +$314K 0.09% 245
2022
Q3
$3.78M Sell
45,698
-309
-0.7% -$25.5K 0.1% 221
2022
Q2
$4.37M Sell
46,007
-17,594
-28% -$1.67M 0.11% 209
2022
Q1
$7.49M Buy
63,601
+163
+0.3% +$19.2K 0.17% 158
2021
Q4
$8.22M Sell
63,438
-1,153
-2% -$149K 0.18% 143
2021
Q3
$7.31M Sell
64,591
-7,694
-11% -$871K 0.17% 145
2021
Q2
$7.49M Sell
72,285
-1,551
-2% -$161K 0.18% 141
2021
Q1
$6.18M Sell
73,836
-873
-1% -$73K 0.15% 160
2020
Q4
$6.82M Sell
74,709
-9,230
-11% -$842K 0.17% 139
2020
Q3
$6.7M Buy
83,939
+217
+0.3% +$17.3K 0.19% 138
2020
Q2
$5.79M Buy
83,722
+4,741
+6% +$328K 0.17% 143
2020
Q1
$4.97M Buy
78,981
+4,161
+6% +$262K 0.18% 142
2019
Q4
$5.82M Sell
74,820
-2,754
-4% -$214K 0.16% 153
2019
Q3
$5.69M Buy
77,574
+20,955
+37% +$1.54M 0.17% 153
2019
Q2
$3.49M Sell
56,619
-1,779
-3% -$110K 0.1% 240
2019
Q1
$3.72M Sell
58,398
-1,770
-3% -$113K 0.11% 225
2018
Q4
$3.07M Sell
60,168
-6,657
-10% -$340K 0.1% 249
2018
Q3
$3.88M Sell
66,825
-4,191
-6% -$243K 0.1% 248
2018
Q2
$3.45M Sell
71,016
-1,830
-3% -$88.8K 0.09% 252
2018
Q1
$3.39M Sell
72,846
-3,720
-5% -$173K 0.09% 280
2017
Q4
$2.88M Buy
76,566
+6,795
+10% +$255K 0.07% 333
2017
Q3
$2.54M Buy
+69,771
New +$2.54M 0.07% 352
2016
Q3
$2.54M Buy
+69,771
New +$2.54M 0.07% 352